Performant Healthcare, Inc. (PHLT)
NASDAQ: PHLT · Real-Time Price · USD
7.60
+0.01 (0.13%)
At close: Aug 26, 2025, 4:00 PM
7.59
-0.01 (-0.13%)
After-hours: Aug 26, 2025, 4:53 PM EDT
Performant Healthcare Stock Forecast
Stock Price Forecast
The 2 analysts that cover Performant Healthcare stock have a consensus rating of "Buy" and an average price target of $7.88, which forecasts a 3.68% increase in the stock price over the next year. The lowest target is $7.75 and the highest is $8.00.
Price Target: $7.88 (+3.68%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Performant Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 1 |
| Hold | 0 | 1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy → Hold Downgrades $7.75 | Strong Buy → Hold | Downgrades | $7.75 | +1.97% | Aug 4, 2025 |
| JMP Securities | JMP Securities | Buy Initiates $8 | Buy | Initiates | $8 | +5.26% | Jul 10, 2025 |
Financial Forecast
Revenue This Year
136.50M
from 122.98M
Increased by 10.99%
Revenue Next Year
152.16M
from 136.50M
Increased by 11.47%
EPS This Year
0.02
from -0.13
EPS Next Year
0.12
from 0.02
Increased by 666.67%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 140.9M | 158.7M | |
| Avg | 136.5M | 152.2M | |
| Low | 130.7M | 143.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 14.6% | 16.2% | |
| Avg | 11.0% | 11.5% | |
| Low | 6.3% | 5.3% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.03 | 0.17 |
| Avg | 0.02 | 0.12 |
| Low | - | 0.07 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | 998.0% |
| Avg | - | 666.7% |
| Low | - | 348.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.